Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Temozolomide IP 250 mg Capsule
Therapeutic Category
Oncology, Anticancer
Dosage Form
Capsule
Packaging Type
in a Bottle
Packaging
5 Capsule
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Temofan 250 Capsule (Temozolomide IP 250 mg) is the largest-dose presentation of this highly specialized, oral cytotoxic chemotherapy, an Alkylating Agent critical for treating the aggressive brain tumor, Glioblastoma Multiforme (GBM).
Mechanism and Impact:Temozolomide acts as a prodrug that rapidly crosses the Blood-Brain Barrier (BBB) before converting to its active form, MTIC, which methylates DNA and induces cell death in tumor cells. The 250 mg Capsule size is vital for achieving the high initial doses required during the concurrent phase with radiation, as well as simplifying the daily pill burden for patients during the long-term adjuvant treatment cycles.
Key Therapeutic Uses:
GBM: Used concurrently with radiation therapy and subsequently as adjuvant monotherapy.
Anaplastic Astrocytoma: Used for patients who have relapsed or progressed.
This high-dose product offers significant commercial value. We offer an exclusive PCD Pharma Franchise opportunity for Temofan 250 Capsule, allowing partners to secure a premium position in the neuro-oncology market.
Common side effects may include low blood pressure, dizziness, cough, high potassium levels, and kidney problems. Rare but serious side effects include swelling of the face or throat (angioedema), severe allergic reactions, or kidney failure. Seek medical attention immediately if you experience severe swelling, difficulty breathing, or sudden swelling.
Used to treat chronic heart failure with reduced ejection fraction and to lower the risk of heart-related complications.
Take this medicine exactly as prescribed by your doctor. Do not stop the medication without consulting your healthcare provider. Regular monitoring of blood pressure, kidney function, and potassium levels is important while on this medication. Inform your doctor if you are pregnant, breastfeeding, have kidney or liver problems, or are taking other medications. Avoid using potassium supplements or salt substitutes unless advised.
Store in a cool, dry place below 30°C, protected from moisture and sunlight. Keep out of reach of children.
Composition : Sacubitril 24 mg + Valsartan 26 mg tablet
Composition : Sacubitril 49 mg + Valsartan 51 mg tablet
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin (5mg) tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Temozolomide IP 250mg Capsule has strong demand in the oncology, neuro-oncology, and specialty healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on oncology and high-value specialty pharmaceutical portfolios.
Medical distributors and agencies can benefit from consistent demand for oncology treatments under specialist medical supervision. Temozolomide IP 250mg is an oral alkylating antineoplastic (chemotherapy) agent used in the treatment of certain brain tumors Commonly prescribed for the management of newly diagnosed glioblastoma multiforme (GBM) in combination with radiotherapy, and for recurrent or refractory anaplastic astrocytoma and other selected brain tumors, as advised by oncologists Helps inhibit the growth and multiplication of cancer cells by damaging their DNA, thereby slowing disease progression High-strength capsule formulation supports individualized chemotherapy dosing according to the patient's body surface area and treatment protocol Requires strict medical supervision with regular monitoring of blood counts, liver function, and overall treatment response due to the risk of bone marrow suppression and other adverse effects Frequently utilized in oncology centers, neuro-oncology clinics, tertiary care hospitals, and cancer specialty hospitals Widely prescribed by medical oncologists, neuro-oncologists, and radiation oncologists This strengthens a comprehensive oncology and specialty healthcare portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Temozolomide IP 250mg Capsule with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent specialty prescription demand, high-value oncology market opportunities, institutional procurement, reliable supply chain support, and attractive margins in the oncology segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality oncology products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.